Intriguingly, IFNγ has previously been shown to increase CML CD34+ CFU numbers [40] and reduce TKI-sensitivity of CML cells in vitro [41]. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.